← ResMed

What podcasts say about ResMed

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about ResMed

3 statements · 1 positive · 1 negative · 1 mixed

  1. Chinese competitors selling similar devices at half price threaten ResMed.

    “The main issue for us is that The devices they make, well, there's some Chinese competitors that make very similar looking devices that seem to do pretty much the same and they sell them for half the price. So I'm very worried about Chinese manufacturing competition”

    Listen at 24:49

    Open the episode · Riding the rebound in CSL, Cochlear and finding the next opportunity
  2. ResMed remains a long-term compounder despite weak market sentiment.

    “it's a continued compounder ResMed, but the market seems out of love with it still.”

    Listen at 10:32

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  3. Jim CramerPositiveOct 6, 2025· Mad Money w/ Jim Cramer

    ResMed is reporting strong results and its stock has risen 23% this year.

    “If you want to play sleep apnea, Resma has been still putting up good numbers, which is why that stock's up 23% for the year.”

    Listen at 35:06

    Open the episode · Mad Money w/ Jim Cramer 10/6/25

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.